Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Proponents often stress the opportunity for substantial therapeutic gains, principally in conditions where conventional medications have proven limited. However, crucially important to consider the considerable financial burden associated with CPI ste